Dashboard
Flat results in Mar 26
- PBT LESS OI(Q) At Rs 1.34 cr has Fallen at -80.5% (vs previous 4Q average)
- NET SALES(Q) At Rs 27.43 cr has Fallen at -11.9% (vs previous 4Q average)
- NON-OPERATING INCOME(Q) is 86.06 % of Profit Before Tax (PBT)
With ROE of 12.8, it has a Expensive valuation with a 5.9 Price to Book Value
Total Returns (Price + Dividend) 
Park Medi World for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Are Park Medi World Ltd latest results good or bad?
Park Medi World Ltd's latest financial results for Q4 FY26 reflect a strong performance in terms of revenue and profit growth, with consolidated net profit reaching ₹70.86 crores, marking a significant year-on-year increase of 55.43%. The company's revenue also showed robust growth, climbing 32.25% year-on-year to ₹460.41 crores, which is the highest quarterly revenue recorded in its recent history. Additionally, the operating margin (excluding other income) improved to 27.66%, indicating enhanced operational efficiency. However, while the headline figures are encouraging, a closer examination reveals volatility in profit across recent quarters. The consolidated net profit exhibited significant fluctuations, with a notable rebound of 39.63% in Q4 FY26 following a sharp decline of 31.01% in Q3 FY26. This pattern raises concerns about the consistency and sustainability of earnings, suggesting that the compan...
Read More
Park Medi World Ltd Quality Grade Upgrade Signals Strengthening Fundamentals
Park Medi World Ltd has seen a notable upgrade in its quality grading from average to good, reflecting significant improvements in its core business fundamentals. This development comes amid a robust performance in key financial metrics such as return on capital employed (ROCE), debt management, and operational efficiency, positioning the small-cap hospital stock as a more attractive proposition for investors seeking quality and consistency in the healthcare sector.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
08-Jun-2026 | Source : BSEMeeting with Analyst/Investors
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
08-Jun-2026 | Source : BSEMeeting with Analysts/Investors
Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
05-Jun-2026 | Source : BSEAnnouncement regarding divestment
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 9 Schemes (5.62%)
Held by 11 FIIs (0.86%)
Ajit Gupta (74.59%)
Kotak Contra Fund (5.07%)
3.96%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is -40.20% vs 40.32% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -40.87% vs 70.29% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 20.51% vs 13.20% in Mar 2025
YoY Growth in year ended Mar 2026 is 28.01% vs 31.37% in Mar 2025